|
|
Volumn 47, Issue 11, 2006, Pages 1183-1185
|
|
Adjuvant therapy of breast cancer with trastuzumab: Herceptin adjuvant (HERA) trial study, B-31 and N9831 study;Mammakarzinom: Adjuvante therapie mit trastuzumab: Herceptin adjuvant (HERA) trial study, B-31- und N9831-studie
a
a
NONE
(Germany)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
PACLITAXEL;
TRASTUZUMAB;
ARTICLE;
BREAST CARCINOMA;
CANCER ADJUVANT THERAPY;
CANCER PATIENT;
CONTROLLED STUDY;
HUMAN;
MAJOR CLINICAL STUDY;
MEDICAL RESEARCH;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
MULTICENTER STUDIES;
NEOPLASM RECURRENCE, LOCAL;
RANDOMIZED CONTROLLED TRIALS;
RECEPTOR, ERBB-2;
TREATMENT OUTCOME;
|
|
EID: 33750906432
PISSN: 00209554
EISSN: None
Source Type: Journal
DOI: 10.1007/s00108-006-1720-x Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
